SRXH

424B3 - SRX Global Inc. (0001471727) (Filer)

424B3 - SRX Global Inc. (0001471727) (Filer)

8-K - SRX Global Inc. (0001471727) (Filer)

NORTH PALM BEACH, Fla., July 16, 2026 (GLOBE NEWSWIRE) -- SRX Global Inc. (NYSE:SRXH) (the "Company", or "SRX"), an AI-enabled platform dedicated to generating returns across high-conviction operating companies and assets, today announced that it has received a written notification from NYSE Regulation confirming that the Company is back in compliance with all NYSE American LLC continued listing standards set forth in Part 10 of the NYSE American Company Guide. In a letter dated July 15, 2026, NYSE Regulation informed the Company that it has resolved the continued listing deficiency with respect to Section 1003(a)(i) and (ii) of the Company Guide, which had been referenced in the Exchange

8-K - SRX Global Inc. (0001471727) (Filer)

EMJX Shifted from "Stress" to "Mixed" for Bitcoin Company Files Updated Investor Presentation Outlining Performance and Strategy Management to Host Fireside Chat Today at 10:30am ET NORTH PALM BEACH, Fla., July 14, 2026 (GLOBE NEWSWIRE) -- SRX Global Inc. (NYSE:SRXH) (the "Company", or "SRX"), an AI-enabled platform dedicated to generating returns across high-conviction operating companies and assets, today reported paper-traded EMJX returns of 26% from February 11, 2026 to July 10, 2026. The EMJX model reads market regime across three states — Bull, Mixed, and Stress — updating every trading day with a forward read on where crypto is heading over roughly the next 30 days. That signal

8-K - SRX Global Inc. (0001471727) (Filer)

NORTH PALM BEACH, Fla., July 10, 2026 (GLOBE NEWSWIRE) -- SRX Global, Inc. (NYSE:SRXH) (the "Company", or "SRX"), an AI-enabled platform dedicated to generating returns across high-conviction operating companies and assets, today announced that Chief Executive Officer, Kent Cunningham, and President of EMJX and Head of Asset Management, Eric Jackson, will participate in a virtual Fireside Chat on Tuesday, July 14, 2026, to discuss recent developments, the completed EMJX acquisition, and vision for the future. SRX Global Fireside Chat Details Date: Tuesday, July 14, 2026Time: 10:30 a.m. ETModerator: Valter Pinto, Managing Director, KCSA Strategic CommunicationsPanelists: Kent Cunningh

NORTH PALM BEACH, Fla., July 09, 2026 (GLOBE NEWSWIRE) -- SRX Global Inc. (NYSE:SRXH) (the "Company", or "SRX"), an AI-enabled platform dedicated to generating long-term shareholder value through investments in high-conviction operating companies and strategic assets, today announced that its Board of Directors has authorized a share repurchase program under which the Company may repurchase up to 10 million shares of its common stock or up to 50% of its shares outstanding. The Company has allocated up to $20 million to repurchase its common stock until July 9, 2027. "With no debt, a strong cash position, and the current market value of our shares, we believe this share repurchase program

Approximately $40 million in cash and more than $15 million in short-term investment assets as of June 30, 20261 Estimated net asset value of approximately $60 million and no debt outstanding as of June 30, 2026¹ Approximately 19.5 million shares outstanding on post 1-for-60 split basis as of July 6, 20261 NORTH PALM BEACH, Fla., July 08, 2026 (GLOBE NEWSWIRE) -- SRX Global Inc. (NYSE:SRXH) (the "Company", or "SRX"), an AI-enabled platform dedicated to generating long-term shareholder value through investments in high-conviction operating companies and strategic assets, today provided shareholders with a preliminary update on certain balance sheet metrics and its capitalization structur

NORTH PALM BEACH, Fla., July 08, 2026 (GLOBE NEWSWIRE) -- SRX Global, Inc. (NYSE:SRXH) (the "Company", or "SRX"), an AI-enabled platform dedicated to generating returns across high-conviction operating companies and assets, today announced that the Board of Directors has approved a one-time cash dividend of $0.05 per share (approximately $1 million in the aggregate) on common stock outstanding to shareholders of record at the close of business on July 22, 2026 (the "Record Date"). The dividend will be paid on or about August 3, 2026 to shareholders of record on Record Date. "This special dividend reflects the strength of our investment strategy and our commitment to returning value direct

S-8 - SRX Global Inc. (0001471727) (Filer)

NORTH PALM BEACH, Fla., July 02, 2026 (GLOBE NEWSWIRE) -- SRX Global, Inc. (NYSE:SRXH) (the "Company", or "SRX"), an AI-enabled platform dedicated to generating returns across high-conviction operating companies and assets, today announced a strategic investment in Greenland Mines Ltd., a critical and precious minerals development company advancing a portfolio of strategic assets in Greenland. About Greenland MinesGreenland Mines Ltd. is a Nasdaq-listed critical and precious minerals development company advancing a portfolio of strategic assets in Greenland. The Company’s strategy is centered on building a multi-asset platform with exposure to rare earth magnet materials, precious metals

8-K - SRX Global Inc. (0001471727) (Filer)

8-K - SRX Global Inc. (0001471727) (Filer)

DEFR14C - SRX Global Inc. (0001471727) (Filer)

NORTH PALM BEACH, Fla., June 24, 2026 (GLOBE NEWSWIRE) -- SRX Global, Inc. (NYSE:SRXH) (the "Company", or "SRX"), an AI-enabled platform dedicated to generating returns across high-conviction operating companies and assets, today announced that its Board of Directors has approved a consolidation of the Company's issued and outstanding common stock on a 60-to-1 basis (the "Share Consolidation"), to be effective July 6, 2026 (the "Effective Date"). On the Effective Date, every 60 shares of issued and outstanding common stock will be automatically combined into one share of common stock. The Company's common stock will continue to trade on the NYSE American under the existing symbol "SRXH" a

NORTH PALM BEACH, Fla., June 23, 2026 (GLOBE NEWSWIRE) -- SRX Global, Inc. (NYSE:SRXH) (the "Company", or "SRX") today announced a strategic investment in ARMR Sciences, a clinical-stage biodefense company developing a platform of medical countermeasures against synthetic drugs, such as fentanyl. ARMR’s lead product, ARMR-100, recently announced it has successfully generated an anti-fentanyl immune response in humans and showed favorable safety data. This marks a critical milestone in the company's path toward demonstrating that this response can protect against fentanyl. ARMR-100 is being designed to work with the body to generate a protective immune response. The product, in a Phase 1/2

8-K - SRx Health Solutions, Inc. (0001471727) (Filer)

Company announces name change to SRX Global in conjunction with transaction closingCompany's stock to remain trading on the NYSE American ("NYSE") under ticker symbol "SRXH" NORTH PALM BEACH, Fla., June 18, 2026 (GLOBE NEWSWIRE) -- SRx Health Solutions, Inc. (NYSE:SRXH) (the "Company", or "SRX") today announced it has completed the acquisition of EMJ Crypto Technologies, Inc. ("EMJX") and is launching its new AI-driven platform strategy, which will focus on driving returns for shareholders through the allocation of capital into high-conviction operating companies and assets. In conjunction with the transaction closing, the Company has changed its legal name and branding to SRX Global Inc

NORTH PALM BEACH, Fla., June 08, 2026 (GLOBE NEWSWIRE) -- SRx Health Solutions, Inc. (NYSE:SRXH) (the "Company") and EMJ Crypto Technologies ("EMJX"), a digital-asset treasury operating platform with which the Company has entered into a definitive merger agreement, today announced acquiring 4.99% of Smartkem, Inc. (NASDAQ:SMTK), a leader in advanced materials, through a shelf take down. In conjunction with the 4.99% of equity, the Company has also purchased convertible preferred securities through a non-brokered private placement. Additional Information and Where to Find It In connection with the proposed transaction between the Company has filed with the SEC a Registration Statement on F

Reduced long position in Compass, Inc., reduced short exposure to Bitcoin and added selective hedges in select international markets  EMJX stress model turned STRESS from MIXED this week – the first negative market reading since the bull rotation beginning on April 4, 2026 NORTH PALM BEACH, Fla., May 29, 2026 (GLOBE NEWSWIRE) -- SRx Health Solutions, Inc. (NYSE:SRXH) (the "Company") and EMJ Crypto Technologies ("EMJX"), a digital-asset treasury operating platform with which the Company has entered into a definitive merger agreement, today provided an update on its portfolio, including the initiation of an investment in Uber Technologies, Inc. "This week, we initiated a position in Uber

NORTH PALM BEACH, Fla., May 21, 2026 (GLOBE NEWSWIRE) -- SRx Health Solutions, Inc. (NYSE:SRXH) (the "Company") and EMJ Crypto Technologies ("EMJX"), a digital-asset treasury operating platform with which the Company has entered into a definitive merger agreement, today announced investing in Optimi Health Corp. (NASDAQ:OPTH), a commercial-stage pharmaceutical company focused on manufacturing and distribution of GMP-grade psychedelic drug products for mental health therapies including Psilocybin. The EMJX proprietary operating system applying quantitative models, artificial intelligence and systematic risk controls has identified Optimi Health Corp. as an investment opportunity for severa

NORTH PALM BEACH, Fla., May 15, 2026 (GLOBE NEWSWIRE) -- SRx Health Solutions, Inc. (NYSE:SRXH) (the "Company") and EMJ Crypto Technologies ("EMJX"), a digital-asset treasury operating platform with which the Company has entered into a definitive merger agreement, today announced board approval to dividend 75% of profits from investment in Astro Investment XVII, an affiliate of Astro Capital and special purpose vehicle (SPV), with investments in SpaceX and other artificial intelligence and space companies. The Company recently announced an investment of greater than 10% of its investable capital in Astro Investment XVII and will return capital to shareholders upon wind down of the SPV. F

10-Q - SRx Health Solutions, Inc. (0001471727) (Filer)